62 related articles for article (PubMed ID: 9219593)
1. Ipriflavone metabolite-III inhibits LPS-induced nitric oxide release from RAW-264.7 cells.
Koncz S; Horváth EJ
Acta Physiol Hung; 1996; 84(3):223-8. PubMed ID: 9219593
[TBL] [Abstract][Full Text] [Related]
2. Glabridin, an isoflavan from licorice root, inhibits inducible nitric-oxide synthase expression and improves survival of mice in experimental model of septic shock.
Kang JS; Yoon YD; Cho IJ; Han MH; Lee CW; Park SK; Kim HM
J Pharmacol Exp Ther; 2005 Mar; 312(3):1187-94. PubMed ID: 15537821
[TBL] [Abstract][Full Text] [Related]
3. Polygonum cuspidatum, compared with baicalin and berberine, inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 macrophages.
Kim KW; Ha KT; Park CS; Jin UH; Chang HW; Lee IS; Kim CH
Vascul Pharmacol; 2007; 47(2-3):99-107. PubMed ID: 17553752
[TBL] [Abstract][Full Text] [Related]
4. C2-ceramide inhibits LPS-induced nitric oxide production in RAW 264.7 macrophage cells through down-regulating the activation of Akt.
Koide N; Sugiyama T; Mori I; Mu MM; Yoshida T; Yokochi T
J Endotoxin Res; 2003; 9(2):85-90. PubMed ID: 12803880
[TBL] [Abstract][Full Text] [Related]
5. 8-Hydroxyquinoline inhibits iNOS expression and nitric oxide production by down-regulating LPS-induced activity of NF-kappaB and C/EBPbeta in Raw 264.7 cells.
Kim YH; Woo KJ; Lim JH; Kim S; Lee TJ; Jung EM; Lee JM; Park JW; Kwon TK
Biochem Biophys Res Commun; 2005 Apr; 329(2):591-7. PubMed ID: 15737626
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase by phenolic (3E)-4-(2-hydroxyphenyl)but-3-en-2-one in RAW 264.7 macrophages.
Tsao LT; Tsai PS; Lin RH; Huang LJ; Kuo SC; Wang JP
Biochem Pharmacol; 2005 Aug; 70(4):618-26. PubMed ID: 15998510
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages.
Kanno S; Shouji A; Tomizawa A; Hiura T; Osanai Y; Ujibe M; Obara Y; Nakahata N; Ishikawa M
Life Sci; 2006 Jan; 78(7):673-81. PubMed ID: 16137700
[TBL] [Abstract][Full Text] [Related]
8. Suppression of lipopolysaccharide-induced expression of inducible nitric oxide synthase by brazilin in RAW 264.7 macrophage cells.
Bae IK; Min HY; Han AR; Seo EK; Lee SK
Eur J Pharmacol; 2005 Apr; 513(3):237-42. PubMed ID: 15862806
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
[TBL] [Abstract][Full Text] [Related]
10. Nicotine enhancement of lipopolysaccharide/interferon-gamma-induced cytotoxicity with elevating nitric oxide production.
Chen YC; Shen SC; Lin HY; Tsai SH; Lee TJ
Toxicol Lett; 2004 Nov; 153(2):191-200. PubMed ID: 15451549
[TBL] [Abstract][Full Text] [Related]
11. Ruthenium complexes as nitric oxide scavengers: a potential therapeutic approach to nitric oxide-mediated diseases.
Fricker SP; Slade E; Powell NA; Vaughan OJ; Henderson GR; Murrer BA; Megson IL; Bisland SK; Flitney FW
Br J Pharmacol; 1997 Dec; 122(7):1441-9. PubMed ID: 9421293
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide inhibits inducible nitric oxide synthase mRNA expression in RAW 264.7 macrophages.
Hinz B; Brune K; Pahl A
Biochem Biophys Res Commun; 2000 May; 271(2):353-7. PubMed ID: 10799301
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide of Helicobacter pylori protects gastric mucosa via generation of nitric oxide.
Brzozowski T; Konturek PC; Sliwowski Z; Drozdowicz D; Pajdo R; Stachura J; Hahn EG; Konturek SJ
J Physiol Pharmacol; 1997 Dec; 48(4):699-717. PubMed ID: 9444618
[TBL] [Abstract][Full Text] [Related]
14. Catecholamines' enhancement of inducible nitric oxide synthase-induced nitric oxide biosynthesis involves CAT-1 and CAT-2A.
Lin WC; Tsai PS; Huang CJ
Anesth Analg; 2005 Jul; 101(1):226-32, table of contents. PubMed ID: 15976236
[TBL] [Abstract][Full Text] [Related]
15. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
Kim CK; Rivier C
J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
[TBL] [Abstract][Full Text] [Related]
16. Macrophage inflammatory protein-1 alpha production in lipopolysaccharide-stimulated human adherent blood mononuclear cells is inhibited by the nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine.
Mühl H; Dinarello CA
J Immunol; 1997 Nov; 159(10):5063-9. PubMed ID: 9366434
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-induced inhibition of nitric oxide production in primary rat hepatocyte cultures via prostaglandin E2 release.
Griffon B; Cillard J; Chevanne M; Morel I; Cillard P; Sergent O
Hepatology; 1998 Nov; 28(5):1300-8. PubMed ID: 9794915
[TBL] [Abstract][Full Text] [Related]
18. Effect of two different groups of Chinese medicines on nitric oxide production by mouse macrophage-like cells.
Kaneko T; Chiba H; Horie N; Hashimoto K; Satoh K; Kusama K; Sakagami H
In Vivo; 2004; 18(6):771-8. PubMed ID: 15646819
[TBL] [Abstract][Full Text] [Related]
19. Glucosamine inhibits LPS-induced COX-2 and iNOS expression in mouse macrophage cells (RAW 264.7) by inhibition of p38-MAP kinase and transcription factor NF-kappaB.
Rafi MM; Yadav PN; Rossi AO
Mol Nutr Food Res; 2007 May; 51(5):587-93. PubMed ID: 17440993
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of ivermectin on nitric oxide and prostaglandin E2 production in LPS-stimulated RAW 264.7 macrophages.
Zhang X; Song Y; Xiong H; Ci X; Li H; Yu L; Zhang L; Deng X
Int Immunopharmacol; 2009 Mar; 9(3):354-9. PubMed ID: 19168156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
